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ABSTRACT
Background: RANTES and eotaxin play an important
role in the production of allergic inflammation of the
airway through a chemotactic activity for eosinophils.
Airway smooth muscle (ASM) cells are known to pro-
duce these cytokines in response to pro-inflammatory
stimuli, such as tumor necrosis factor (TNF)-α; how-
ever, it has not been determined whether mechanical
strain could induce cytokine production by ASM cells.
In addition, in the present study we also examined the
effect of inhalant corticosteroids, namely fluticasone
propionate (FP) and budesonide (BUD), on RANTES
and eotaxin production.
Methods: To clarify these issues, human ASM cells
cultured on silicone culture rubber dishes that had
been incubated with or without inhalant corticosteroids
were stretched or compressed. The ASM cells were
simultaneously stimulated with TNF-α. The concentra-
tion of RANTES and eotaxin in the culture supernatants
was determined.
Results: The results showed that: (i) mechanical
strain, including stretch and compression, stimulated
ASM cells to produce RANTES and eotaxin; and (ii) FP
and BUD inhibited mechanical strain-induced and
TNF-α-stimulated RANTES and eotaxin production 
by ASM cells. These results indicate that mechanical
strain is capable of inducing RANTES and eotaxin 
production by ASM cells and that inhalant cortico-
steroids effectively inhibit RANTES and eotaxin produc-
tion by mechanical strain-loaded ASM cells, as well as
by TNF-α-stimulated cells.
Conclusions: Mechanical strain and inflammatory
stimuli are capable of inducing chemokine production;
therefore, suppressing the contraction of, as well as
chemokine production by, ASM cells is important for
controlling the production and the progression of
allergic inflammation.
Key words: airway smooth muscle cells, eotaxin,
inhaled corticosteroids, mechanical strain, RANTES.
INTRODUCTION
Bronchial asthma is a disease that is characterized by
episodic reversible airway obstruction, airway hyper-
responsiveness and allergic inflammation in the airway.1
A variety of cells produce cytokines, which participate in
the production of allergic inflammation.2–5 Of these cells,
airway smooth muscle (ASM) cells, which have been
regarded as having contractile properties in response to
contractile inflammatory mediators, may also participate
in the production of allergic inflammation by expressing
various cytokines.6–10 Many elements and circumstances
are capable of inducing cytokine production by ASM
cells. Pro-inflammatory cytokines and chemical media-
tors have been shown to stimulate ASM cells to produce
various cytokines.6–12 In addition, mechanical strain is a
candidate as an inducer of cytokine production by ASM
cells because it has been shown that mechanical strain
can induce various factors, such as fibronectin by mesan-
gial cells,13 type I collagen by pulmonary fibroblasts,14
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and interleukin (IL)-8 by alveolar epithelial cells.15
However, the effect of mechanical strain on cytokine pro-
duction by ASM cells has not been determined. In the
allergic inflammation of asthmatic airway, eosinophils
play a pivotal role in the production of allergic inflamma-
tion.16 RANTES and eotaxin are involved in the produc-
tion of allergic inflammation through their chemotactic
activity for eosinophils.2–5,17 Consequently, in the present
study, we measured the concentrations of RANTES and
eotaxin.
Inhaled corticosteroids, including beclomethasone
dipropionate (BDP), fluticasone propionate (FP) and
budesonide (BUD), reduce airway inflammation and
airway hyperresponsiveness and are used widely for 
the treatment of bronchial asthma.18–21 Corticosteroids,
including inhalant corticosteroids, are reported to inhibit
cytokine production;21 however, the effect of FP and BUD
on mechanical strain-induced cytokine production has
not been determined. In the present study, we also
attempted to examine the effect of the inhalant cortico-
steroids FP and BUD on mechanical strain-induced
RANTES and eotaxin production to clarify these issues.
METHODS
Reagents
Fluticasone propionate and BUD were kindly provided 
by GlaxoWelcome Ltd (Tokyo, Japan) and Astra Japan
Inc. (Tokyo, Japan). Human recombinant tumor necrosis
factor (TNF)-α was kindly provided by Dainippon
Pharmaceutical Co. Ltd (Osaka, Japan). Anti-human 
IL-1β monoclonal antibody (mAb) and antihuman TNF-α
mAb were obtained from Genzyme (Cambridge, MA,
USA).
Cell culture
Human bronchial smooth muscle (BSM) cells derived
from normal healthy subjects used as ASM cells in the
present study were obtained from Clonetics (San Diego,
CA, USA). We used silicone rubber culture dishes (Shin-
Etsu Chemical, Tokyo, Japan) for this study, as described
previously.22 Cells (1 × 104 cells/mL) were placed onto
silicone rubber culture dishes coated with collagen type I
(Sigma Chemical, St Louis, MO, USA) and cultured using
BSM cell growth medium (SmBM; Clonetics) containing
5% fetal bovine serum (FBS), gentamycin–amphotericin
B, epidermal growth factor (EGF), fibroblast growth
factor (FGF) and dexamethasone (DEX) at 37°C in
humidified 5% CO2 atmosphere. In order to examine
mechanical strain-induced cytokine production, DNA
synthesis and cell proliferation, ASM cells were allowed to
reach subconfluence (approximately 2 × 104 cells/mL);
at that time, the culture medium was replaced with SmBM
containing 0.1% FBS and cells were cultured for 16 h. At
the end of depletion of growth factors, ASM cells were
loaded by mechanical strain in the presence of SmBM
containing 0.1% FBS. The ASM cells at passage numbers
3–5 were used for experiments. At confluence of each
passage, using immunofluorescence techniques for both
smooth muscle actin and myosin, more than 95% of cells
displayed the characteristics of smooth muscle cells in
culture.
Mechanical strain
Effect of stretch
The ASM cells cultured on silicone culture rubber dishes
were stretched by 20% as described previously.22,23
Briefly, the silicone rubber culture dish was fixed to the
sides of the stretch frame, which was designed so that
the silicone rubber culture dish was mechanically expan-
ded by 20%, thereby uniaxillary increasing the length of
the attached cells.
Effect of compression
The ASM cells were cultured on a stretched silicone
rubber culture dish that had been fixed to the sides of the
stretch frame in order to stretch the silicone rubber culture
dish. To compress ASM cells, the stretched silicone rubber
culture dish was detached from the frame.
Stretch and compression were performed in a sterile
laminar flow hood. After completing these procedures,
the silicone rubber dishes, kept in a Petri dish, were incu-
bated at 37°C in humidified 5% CO2 atmosphere. In
order to examine the effect of inhalant corticosteroids on
mechanical strain-induced cytokine production, DNA
synthesis and cell proliferation, ASM cells that had been
pre-incubated with various concentrations of BDP or BUD
(10–6 to 10–8 mol/L) for 1 h were stretched or com-
pressed. For control cultures, unstretched control ASM
cells and uncompressed control ASM cells were simulta-
neously cultured on silicone rubber culture dishes. In
order to examine the effect of anti-TNF-α mAb and anti-
IL-1β mAb on mechanical strain-induced cytokine pro-
duction, ASM cells that had been pre-incubated with
either mAb for 1 h were stretched or compressed.
Cytokine production
After completion of stretching or compression of the cells,
the silicone rubber culture dish, kept in a Petri dish, was
incubated at 37°C in humidified 5% CO2 atmosphere
and the culture supernatant was harvested at 12, 24 and
48 h after cultivation. The culture supernatants from ASM
cells stimulated with TNF-α were harvested at 24 h.
DNA synthesis and cell number determination
DNA synthesis in ASM cells was measured by [3H]-
thymidine incorporation. After completion of stretching or
compression of the cells, the silicone rubber culture dish,
kept in a Petri dish, was incubated at 37°C in humidified
5% CO2 atmosphere for 24 and 48 h. [3H]-Thymidine
was added to cell culture dishes for the last 4 h of the
incubation period. After incubation, cells were trypsinized
and transferred to flat-bottomed 96-well culture plates
and harvested onto glass fiber strips with a cell harvester.
Retained radioactivity was counted in a scintillation
counter. In order to determine cell proliferation, cells
were trypsinized and counted at 24 and 48 h after 
cultivation.
Measurement of cytokine
The concentrations of RANTES, eotaxin, TNF-α and IL-1β
in the culture supernatants from ASM cells were mea-
sured by commercially available ELISA kits (Amersham
International, Aylesbury, UK). The ELISA was performed
according to the manufacturer’s instructions. All samples
were assayed in duplicate.
Statistical analysis
Statistical significance was analyzed with analysis of
variance (ANOVA). P < 0.05 was considered significant.
When statistical significance was reached, post hoc tests
(Fischer’s Protected Least Significant Difference, Scheffé’s
F-test) were performed.
RESULTS
Mechanical strain induces RANTES and 
eotaxin production
The concentrations of RANTES and eotaxin in the culture
supernatants from mechanical strain-loaded ASM cells
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Fig. 1 Mechanical strain induces
RANTES and eotaxin production.
Airway smooth muscle (ASM) cells
cultured on silicone culture rubber
dishes were stretched (a,b) or com-
pressed (c,d) and cultured for 12,
24 and 48 h. The concentration of
RANTES (a,c) and eotaxin (b,d) 
in culture supernatants from (a,b)
stretched cells () and (c,d) com-
pressed cells () was determined.
The concentration of RANTES (a,c)
and eotaxin (b,d) in culture super-
natants from (a,b) unstretched
control ASM cells () and (c,d)
uncompressed control ASM cells
(), which were simultaneously 
cultured on silicone rubber culture
dishes, was determined. Results are
expressed as the mean±SD of 
six different experiments. *P < 0.01
compared with unstretched control
ASM cell culture (a,b) or uncom-
pressed control ASM cell culture
(c,d).
and control cells at 12, 24 and 48 h after cultivation were
determined. The concentration of RANTES in the super-
natants from stretched cells was maximal at 24 h after
cultivation (Fig. 1a). Similarly, the concentration of
eotaxin was maximal at 24 h after cultivation (Fig. 1b). In
compressed cells, the concentrations of RANTES and
eotaxin were maximal at 24 h after cultivation (Fig. 1c,d).
It may be possible that cytokines, including TNF-α and 
IL-1β, produced by mechanical strain-loaded ASM cells
are responsible for the induction of RANTES and eotaxin.
To test this possibility, the concentrations of RANTES and
eotaxin in the culture supernatants from mechanical
strain-loaded ASM cells and control cells in the presence
of anti-IL-1β mAb or anti-TNF-α mAb at 24 h after culti-
vation were determined. Neither Ab had any effect on the
concentration of RANTES and eotaxin (data not shown).
In addition, we measured the concentrations of TNF-α
and IL-1β in culture supernatants from mechanical
strain-loaded ASM cell cultures using a specific ELISA.
The concentrations of these cytokines were below the
sensitivity limit of the assay (data not shown). In the
present study, we used sufficient concentrations of mAbs
for neutralizing corresponding cytokine activity of assay
sensitivity limit.
Inhalant corticosteroids inhibit mechanical strain-
induced RANTES and eotaxin production. We examined
the effect of FP and BUD on mechanical strain-induced
RANTES and eotaxin production. To this end, the concen-
trations of RANTES and eotaxin at 24 h were determined.
In stretched cells, FP inhibited mechanical strain-induced
RANTES and eotaxin production in a dose-dependent
manner (Fig. 2a,b). Similarly, BUD inhibited mechanical
strain-induced RANTES and eotaxin production in a
dose-dependent manner (Fig. 2c,d). Similar observations
were obtained in compressed cells (Fig. 3a–d). Inhalant
corticosteroids inhibit TNF-α-induced RANTES and eotaxin
production We examined the effect of FP and BUD 
on TNF-α-induced RANTES and eotaxin production. To
this end, the concentrations of RANTES and eotaxin at 
24 h were determined. Fluticasone propionate inhibited 
TNF-α-induced RANTES and eotaxin production in a
dose-dependent manner (Fig. 4a,b). Similarly, BUD
inhibited TNF-α-induced RANTES and eotaxin produc-
tion in a dose-dependent manner (Fig. 4c,d).
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Fig. 2 Inhalant corticosteroids
inhibit RANTES and eotaxin
production by stretched airway
smooth muscle (ASM) cells. The
ASM cells cultured on silicone
culture rubber dishes that had
been incubated with various
concentrations of (a,b) fluticas-
one propionate (FP) and (c,d)
budesonide (BUD) for 1 h were
stretched by 20% or unstretched
and cultured for 24 h. The con-
centrations of (a,c) RANTES and
(b,d) eotaxin in culture super-
natants from stretched cells ()
and from unstretched control
ASM cells () were determined.
Results are expressed as the
mean±SD of six different experi-
ments. *P < 0.01, †P < 0.05
compared with FP- or BUD-
untreated and stretched control
ASM cell culture.
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Fig. 3 Inhalant corticosteroids
inhibit RANTES and eotaxin pro-
duction by compressed airway
smooth muscle (ASM) cells. The
ASM cells cultured on stretched
silicone rubber culture dishes
that had been incubated with
various concentrations of (a,b)
fluticasone propionate (FP) and
(c,d) budesonide (BUD) for 1 h
were compressed by detaching
the silicone rubber culture dish
from the frame or uncompressed
and cultured for 24 h. The con-
centration of (a,c) RANTES and
(b,d) eotaxin in culture super-
natants from compressed cells
() and uncompressed control
ASM cells () was determined.
Results are expressed as the
mean±SD of six different experi-
ments. *P < 0.01, †P < 0.05
compared with FP- or BUD-
untreated and stretched control
ASM cell culture.
Fig. 4 Inhalant corticosteroids
inhibit tumor necrosis factor
(TNF)-α-induced RANTES and
eotaxin production. Airway
smooth muscle (ASM) cells cul-
tured on silicone culture rubber
dishes that had been incubated
with various concentrations of
(a,b) fluticasone propionate (FP)
and (c,d) budesonide (BUD) for
1 h were cultured with 10 ng/mL
TNF-α or medium for 24 h. The
concentration of (a,c) RANTES
and (b,d) eotaxin in the TNF-α-
stimulated () and control ()
cultures was determined as
described in Methods. Results
are expressed as the mean±SD
of six different experiments. 
*P < 0.01, †P < 0.05 compared
with the unstimulated ASM cell
culture.
DNA synthesis and cell proliferation
Finally, we examined the dependence of increased cyto-
kine production on ongoing cell growth. Simultaneously,
we examined the dependence of decreased cytokine
production by inhalant corticosteroid-treated cells on
suppressed cell growth. There was no significant change
in the rate of DNA synthesis and the cell number between
mechanical strain-loaded cells and control cells at 24 h
after cultivation (Fig. 5). There was no effect of FP on
DNA synthesis and cell number in either stretched 
(Fig. 5a,b) or compressed (Fig. 5c,d) cells at 24 h after
cultivation. Similar results were obtained in BUD-treated
cell cultures (data not shown). When the rate of DNA 
synthesis, the cell number and the effect of FP and BUD
on them were determined at 48 h, similar results were
obtained (data not shown). Cell viability, determined by
trypan blue dye exclusion at the end of the culture period
of each experiment, did not differ with culture conditions
(data not shown).
DISCUSSION
In the present study, we measured the concentration of
RANTES and eotaxin in culture supernatants from stretched
and compressed ASM cells in order to examine whether
mechanical strain could activate ASM cells to produce
RANTES and eotaxin. We also examined the effect of the
inhalant corticosteroids FP and BUD on mechanical
strain-induced RANTES and eotaxin production. The
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Fig. 5 DNA synthesis and cell proliferation. Airway smooth muscle (ASM) cells cultured on silicone culture rubber dishes that had
been incubated with 10–6 mol/L fluticasone propionate (FP) or 0–6 mol/L budesonide (BUD) for 1 h were stretched (a,b) or com-
pressed (c,d) and cultured for 24 h. DNA synthesis in ASM cells was measured by [3H]-thymidine incorporation (a,c). The number of
cells was counted (b,d). Results are expressed as the mean±SD of four different experiments.
results showed that: (i) mechanical strain stimulates 
ASM cells to produce RANTES and eotaxin production;
(ii) neutralizing anti-TNF-α mAb and anti-IL-1β mAb did
not affect the concentration of RANTES and eotaxin from
mechanical strain-loaded ASM cells; and (iii) FP and
BUP inhibited mechanical strain-induced and TNF-α-
stimulated RANTES and eotaxin production by ASM cells
in a dose-dependent manner. These results indicate that
mechanical strain is capable of inducing RANTES and
eotaxin production by ASM cells and TNF-α and IL-1β
are not involved in mechanical strain-induced RANTES
and eotaxin production. However, the roles of other
cytokines in mechanical strain-induced RANTES and
eotaxin production remain to be determined. Fluticasone
propionate and BUD effectively inhibit RANTES and
eotaxin production by mechanical strain-loaded ASM
cells as well as by TNF-α-stimulated ASM cells.
There are several possible mechanisms by which
mechanical strain induces RANTES and eotaxin pro-
duction. Mechanical strain has been shown to activate
various biochemical molecules in cells, including 
extracellular-signal regulated kinase (Erk).23,24 We have
shown previously that mechanical strain activates Erk in
ASM cells.23 In the present study, we examined the effect
of PD 98059 as an inhibitor of MEK-1, an upstream
kinase of Erk,25 on mechanical strain-induced RANTES
and eotaxin production (data not shown). The results
showed that PD 98059 did not inhibit mechanical strain-
induced RANTES and eotaxin produciton, indicating that
Erk is not involved in RANTES and eotaxin production by
mechanical strain-loaded ASM cells. Further studies are
needed to clarify the intracellular signaling cascade
leading to RANTES and eotaxin production by mechani-
cal strain-loaded ASM cells.
RANTES and eotaxin, which display a chemotactic
activity for eosinophils, play an important role in the 
production of allergic inflammation.2–5,17 Many elements
and circumstances are capable of inducing cytokine pro-
duction. Increasingly, it is recognized that structural cells
in the airway, such as epithelial cells, smooth muscle
cells, fibroblasts and endothelial cells, produce inflam-
matory mediators and cytokines and participate in the
production of allergic inflammation.2–10,26 Therefore, it is
important to clarify the mechanism of cytokine produc-
tion by structural cells. The ASM cells are known to
produce various cytokines. It has been documented that
receptor-mediated signals including proinflammatory
cytokine signals induce cytokine production; however,
little is known about the effect of mechanical strain on
cytokine production. The present study showed that
mechanical strain as well as proinflammatory cytokines,
TNF-α, induced RANTES and eotaxin production by ASM
cells. These results indicate new evidences on the mecha-
nism in the production of RANTES and eotaxin, which is
that mechanical strain, is capable of inducing the pro-
duction of RANTES and eotaxin.
It is conceivable that mechanical strain on ASM cells
may occur during an asthma attack. Although the mech-
anical strain regimen used in the present study is differ-
ent from the physiological situation, the results of the
present study indicate that ASM contractility causes not
only airflow limitation, but also the induction of cytokines.
In addition, the present study indicates that mechanical
strain-loaded ASM cells could amplify allergic inflamma-
tion by means of the production of RANTES and eotaxin.
In this context, the inhibition of the production of RANTES
and eotaxin by mechanical strain-loaded ASM cells is an
important strategy for the attenuation of the progression
of allergic inflammation. Corticosteroids, including inhalant
corticosteroids, have been shown to inhibit cytokine pro-
duction by a variety of cells in response to inflammatory
stimuli, such as pro-inflammatory cytokines,21 whereas
their efficacy on mechanical strain-induced cytokine pro-
duction has not been determined. The present study
showed that FP and BUD inhibited RANTES and eotaxin
production by mechanical strain-loaded ASM cells as
well as by TNF-α-stimulated ASM cells. Inhaled cortico-
steroids, which reduce airway inflammation and airway
hyperresponsiveness, are used widely for the treatment of
bronchial asthma.18–21 Inhaled corticosteroids are recom-
mended as first-line therapy for all patients with persistent
symptoms and their efficacy has been established.27 From
the present results, we would like to emphasise that
inhalant corticosteroids are capable of producing bene-
ficial effects on controlling the production and the pro-
gression of allergic inflammation.
From the data presented here, we conclude that, 
in addition to contractile properties, ASM cells may be 
a source of chemokine, thus implicating ASM cells as
contributors to the allergic inflammatory process of
asthma. Mechanical strain, as well as inflammatory
stimuli, is capable of inducing chemokine production;
therefore, suppressing the contraction of, as well as
chemokine production by, ASM cells is important for
controlling the production and the progression of aller-
gic inflammation. In this context, ASM cells should be
considered as targets for anti-inflammatory therapy, such
as inhaled corticosteroids.
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